Bionano Genomics (BNGO) Gains from Investment Securities (2017 - 2026)
Bionano Genomics' (BNGO) quarterly Gains from Investment Securities came in at $443000.0 in Q1 2026, up 234.24% year-on-year from $132538.5 in Q1 2025, and up 34.65% quarter-over-quarter from $329000.0 in Q4 2025.
Bionano Genomics (BNGO) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Bionano Genomics has disclosed Gains from Investment Securities across 8 years of filings, most recently posting $443000.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $443000.0, up 234.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $443000.0 (up 115.24% YoY), and the FY2025 annual result was $190000.0, up 239.29% from the prior year.
- Gains from Investment Securities came in at $443000.0 for Q1 2026 at Bionano Genomics, up from $329000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $500000.0 in Q3 2022 to a low of -$1.4 million in Q4 2024.
- The 5-year median for Gains from Investment Securities is -$45000.0 (2023), against an average of -$251533.3.
- Peak annual rise in Gains from Investment Securities reached 1109.09% in 2024, while the deepest fall reached 3011.11% in 2024.
- Bionano Genomics' Gains from Investment Securities stood at -$481000.0 in 2022, then slumped by 199.17% to -$1.4 million in 2023, then retreated by 0.28% to -$1.4 million in 2024, then soared by 122.8% to $329000.0 in 2025, then jumped by 34.65% to $443000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $443000.0 (Q1 2026), $329000.0 (Q4 2025), and -$258000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Bionano Genomics | 14.01 Mn | -366,620.40 | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 443,000.00 |
| Mar 31, 2026 | 443,000.00 |
| Dec 31, 2025 | 329,000.00 |
| Dec 31, 2025 | 329,000.00 |
| Sep 30, 2025 | -258,000.00 |
| Sep 30, 2025 | -258,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Mar 31, 2025 | -330,000.00 |
| Mar 31, 2025 | -330,000.00 |
| Dec 31, 2024 | -1.44 Mn |
| Dec 31, 2024 | -1.44 Mn |
| Sep 30, 2024 | -1.40 Mn |
| Sep 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | 266,000.00 |
| Jun 30, 2024 | 266,000.00 |
| Mar 31, 2024 | -284,000.00 |
| Mar 31, 2024 | -284,000.00 |
| Dec 31, 2023 | -1.44 Mn |
| Dec 31, 2023 | -1.44 Mn |